Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia

Morley, N.J. and Marks, D.I. (2016) Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia. Expert Review of Anticancer Therapy, 16 (2). pp. 159-164. ISSN 1473-7140

Abstract

Metadata

Authors/Creators:
  • Morley, N.J.
  • Marks, D.I.
Copyright, Publisher and Additional Information: © 2016 Taylor & Francis. This is an author produced version of a paper subsequently published in Expert Review of Anticancer Therapy. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Acute lymphoblastic leukaemia; Inotuzumab Ozogamicin; CD22; calicheamicin; veno-occlusive disease of the liver; relapse
Dates:
  • Published (online): 28 January 2016
  • Accepted: 10 December 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 03 Mar 2016 17:12
Last Modified: 14 Apr 2017 03:05
Published Version: http://dx.doi.org/10.1586/14737140.2016.1131614
Status: Published
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1586/14737140.2016.1131614

Share / Export

Statistics